# STOCKHOLM 1.0
#=GF ID   CXCR4_N
#=GF AC   PF12109.12
#=GF DE   CXCR4 Chemokine receptor N terminal
#=GF AU   Mistry J;0000-0003-2479-5322
#=GF AU   Gavin OL;
#=GF SE   pdb_2k03
#=GF GA   26.00 26.00;
#=GF TC   26.80 26.00;
#=GF NC   25.40 24.80;
#=GF BM   hmmbuild HMM.ann SEED.ann
#=GF SM   hmmsearch -Z 75585367 --cpu 4 -E 1000 HMM pfamseq
#=GF TP   Domain
#=GF RN   [1]
#=GF RM   18799424
#=GF RT   Structural basis of CXCR4 sulfotyrosine recognition by the
#=GF RT   chemokine SDF-1/CXCL12.
#=GF RA   Veldkamp CT, Seibert C, Peterson FC, De la Cruz NB, Haugner JC
#=GF RA   3rd, Basnet H, Sakmar TP, Volkman BF;
#=GF RL   Sci Signal. 2008;1:ra4.
#=GF DR   INTERPRO; IPR022726;
#=GF DR   SO; 0000417; polypeptide_domain;
#=GF CC   CXCR4 and its ligand stromal cell-derived factor-1 (a.k.a.
#=GF CC   CXCL12) are essential for proper fetal development. CXCR4 is
#=GF CC   also the major coreceptor for T-tropic strains of human
#=GF CC   immunodeficiency virus 1 (HIV-1), and SDF-1 inhibits HIV-1
#=GF CC   infection. Additionally, SDF-1 and CXCR4 mediate cancer cell
#=GF CC   migration and metastasis. The N terminal domain of most
#=GF CC   chemokine receptors is the ligand binding domain and so the N
#=GF CC   terminal domain of CXCR4 is the binding site for SDF-1. [1]
#=GF SQ   6
#=GS G1K8R1_ANOCA/9-41       AC G1K8R1.2
#=GS H0ZNK3_TAEGU/100-132    AC H0ZNK3.2
#=GS G1NRY9_MELGA/16-48      AC G1NRY9.3
#=GS G1SGF1_RABIT/6-38       AC G1SGF1.2
#=GS CXCR4_XENTR/10-42       AC Q07FZ4.1
#=GS A0A5F8GXR2_MONDO/16-48  AC A0A5F8GXR2.1
G1K8R1_ANOCA/9-41                  IFMTENSTD.EPGSGDDGDYQEVCLQQENADFNR
H0ZNK3_TAEGU/100-132               IELSENGTD.EIGSGDYGDYKEPCYQNENADFNR
G1NRY9_MELGA/16-48                 IEFADNGSE.EIGSADYGDYGEPCFQHENADFNR
G1SGF1_RABIT/6-38                  IYTSDNYTE.ELGSGDYDSIKEPCFREENAHFNR
CXCR4_XENTR/10-42                  INIFDSNST.ENGSGDFEDFSEPCFMHDNSDFNR
A0A5F8GXR2_MONDO/16-48             IEFHDNNTVEGFGSGDYEG.KEPCYPNENEDFNR
#=GC seq_cons                      IphsDNsT-.EhGSGDYsDapEPCappENADFNR
